Literature DB >> 1185151

Integration and sealing-over as recovery styles from acute psychosis.

S T Levy, T H McGlashan, W T Carpenter.   

Abstract

Integration and sealing-over are terms frequently used to describe different types of recovery from acute psychosis. Metapsychological and dynamic propositions regarding integration and sealing-over as recovery styles are presented and illustrated with clinical case material. Particular emphasis is placed on the different modes of conflict resolution characteristic of integration and sealing-over. The ego operations underlying these modes of conflict resolution are discussed.

Entities:  

Mesh:

Year:  1975        PMID: 1185151

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  5 in total

1.  Toward understanding the insight paradox: internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders.

Authors:  Paul H Lysaker; David Roe; Philip T Yanos
Journal:  Schizophr Bull       Date:  2006-08-07       Impact factor: 9.306

2.  Call it a monster for lack of anything else: narrative insight in psychosis.

Authors:  David Roe; Ilanit Hasson-Ohayon; Shlomo Kravetz; Phil T Yanos; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2008-12       Impact factor: 2.254

Review 3.  Pharmacological management of first-episode schizophrenia and related nonaffective psychoses.

Authors:  Daniel W Bradford; Diana O Perkins; Jeffrey A Lieberman
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Insight, distress and coping styles in schizophrenia.

Authors:  Michael Cooke; Emmanuelle Peters; Dominic Fannon; Anantha P P Anilkumar; Ingrid Aasen; Elizabeth Kuipers; Veena Kumari
Journal:  Schizophr Res       Date:  2007-06-11       Impact factor: 4.939

5.  Depressive symptoms in first episode psychosis: a one-year follow-up study.

Authors:  Nasrettin Sönmez; Kristin Lie Romm; Ole A Andreasssen; Ingrid Melle; Jan Ivar Røssberg
Journal:  BMC Psychiatry       Date:  2013-04-05       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.